Targeting the microbiome in pediatric migraine: gastrointestinal manifestations and the therapeutic role of Bifidobacterium longum.

Researchers studied 126 children and teenagers with migraines to understand the connection between gut health and headaches. They discovered that young migraine patients have different gut bacteria compared to healthy children, specifically showing lower levels of a beneficial bacteria called Bifidobacterium longum and higher levels of other bacteria like Bacteroides. Nearly half of the migraine patients also experienced gastrointestinal problems like abdominal pain, and these children had more severe migraines and greater disability from their headaches. The study found that certain gut bacteria were linked to milder symptoms, while others were associated with more severe disease. When researchers tested B. longum supplementation in animal models and a small group of 23 pediatric migraine patients, they observed promising results: the probiotic reduced headache frequency, intensity, and the number of headache days. This research is significant because it suggests that migraine in young people may be connected to an imbalance in gut bacteria, and that restoring healthy bacteria through probiotics could offer a new treatment approach. For patients considering complementary therapies like acupuncture for pediatric migraines, this research supports the importance of addressing multiple body systems, as both gut health and neurological function appear interconnected in this condition. Working with a qualified, licensed acupuncturist experienced in treating pediatric headaches can help develop an integrative treatment plan.

This prospective study enrolled 126 pediatric migraine patients (ages 6-19) and 50 healthy controls, using 16S rRNA sequencing to profile fecal microbiota. Key findings revealed reduced Bifidobacterium longum and elevated Bacteroides in migraine patients compared to controls. Among migraine patients, 46.8% presented with Rome IV-defined GI disorders, showing significantly higher abdominal pain rates (50% vs. 13%, p<0.001), greater disability scores (PedMIDAS: 60±13.2 vs. 29±7.0, p=0.042), elevated fecal calprotectin, and enrichment of Streptococcus gallolyticus. Faecalibacterium prausnitzii positively correlated with B. longum and milder symptoms. Animal models demonstrated B. longum attenuated trigeminal activation. An exploratory pilot study (n=23) showed B. longum supplementation reduced headache days, intensity, and frequency. Clinical relevance: Gut dysbiosis represents a therapeutic target in pediatric migraine, with microbiota-directed interventions offering potential adjunctive treatment alongside conventional and complementary approaches including acupuncture.